Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders
View ORCID ProfileJudit Cabana-Domínguez, Bàrbara Torrico, View ORCID ProfileAndreas Reif, View ORCID ProfileNoèlia Fernàndez-Castillo, View ORCID ProfileBru Cormand
doi: https://doi.org/10.1101/2020.06.30.20143404
Judit Cabana-Domínguez
1Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Catalonia, Spain
2Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Spain
3Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Catalonia, Spain
4Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Catalonia, Spain
PhDBàrbara Torrico
1Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Catalonia, Spain
2Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Spain
3Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Catalonia, Spain
4Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Catalonia, Spain
PhDAndreas Reif
5Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany
PhDNoèlia Fernàndez-Castillo
1Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Catalonia, Spain
2Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Spain
3Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Catalonia, Spain
4Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Catalonia, Spain
PhDBru Cormand
1Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Catalonia, Spain
2Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Spain
3Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Catalonia, Spain
4Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Catalonia, Spain
PhDArticle usage
Posted July 03, 2020.
Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders
Judit Cabana-Domínguez, Bàrbara Torrico, Andreas Reif, Noèlia Fernàndez-Castillo, Bru Cormand
medRxiv 2020.06.30.20143404; doi: https://doi.org/10.1101/2020.06.30.20143404
Subject Area
Subject Areas
- Addiction Medicine (381)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2832)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12531)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4408)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2837)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4167)
- Nursing (220)
- Nutrition (615)
- Oncology (2194)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6752)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (365)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)